BRIEF-Solid Biosciences Provides Update On SGT-001 Clinical Development Program For Duchenne Muscular Dystrophy [Reuters]
Solid Biosciences Inc. (SLDB)
Last solid biosciences inc. earnings: 8/14 07:25 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.solidbio.com/investor-relations
Company Research
Source: Reuters
BRIEF-Solid Biosciences Provides Update On SGT-001 Clinical Development Program For Duchenne Muscular Dystrophy | Reuters Reuters Staff 1 Min Read April 18 (Reuters) - Solid Biosciences Inc: * SOLID BIOSCIENCES PROVIDES UPDATE ON SGT-001 CLINICAL DEVELOPMENT PROGRAM FOR DUCHENNE MUSCULAR DYSTROPHY * SOLID BIOSCIENCES INC - FULL CLINICAL HOLD LETTER FROM FDA RECEIVED; COMPANY TO RESPOND IN COMING WEEKS * SOLID BIOSCIENCES INC - MANUFACTURING-RELATED PARTIAL CLINICAL HOLD ON HIGH DOSE OF SGT-001 RESOLVED * SOLID BIOSCIENCES - GOT LETTER FROM U.S. FDA RELATING TO PREVIOUSLY-ANNOUNCED FULL CLINICAL HOLD ON IGNITE DMD TRIAL * SOLID BIOSCIENCES - FULL CLINICAL HOLD WAS IN RESPONSE TO CO’S REPORT OF A SERIOUS ADVERSE EVENT IN FIRST PATIENT DOSED WITH SGT-001 IN IGNITE DMD * SOLID BIOSCIENCES - FDA SAYS CO ADDRESSED MANUFACTURING-RELATED QUESTIONS LEADING TO PARTIAL CLINICAL HOLD ON HIGH DOSE OF SGT-001 IN IGNITE DMD Source text for Eikon: Further company coverage: All quotes delayed a minim
Show less
Read more
Impact Snapshot
Event Time:
SLDB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SLDB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SLDB alerts
High impacting Solid Biosciences Inc. news events
Weekly update
A roundup of the hottest topics
SLDB
News
- Buy Solid Biosciences: Unpacking Its Main Value Driver [Seeking Alpha]Seeking Alpha
- British billionaire fined $5M, sentenced to 3 years probation for insider trading [Yahoo! Finance]Yahoo! Finance
- Joe Lewis: How one of Britain's richest people broke insider trading laws [Yahoo! Finance]Yahoo! Finance
- Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]Yahoo! Finance
- Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
SLDB
Earnings
- 11/8/23 - Beat
SLDB
Sec Filings
- 4/12/24 - Form PRE
- 4/5/24 - Form 4
- 3/13/24 - Form S-3
- SLDB's page on the SEC website